International Clinical Trial: A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07823608) titled 'A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)' on Sept. 11.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: Pfizer

Condition: Apnea Sleep Disorders Overweight and/or Obesity

Intervention: Drug: Berobenatide

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: September 19,...